二重荧光RT-LAMP方法鉴别检测口蹄疫病毒和水泡性口炎病毒

口蹄疫和水泡性口炎是牛常见高度急性病毒传染病,在全球范围内广泛存在。本研究旨在建立一种可同时鉴别口蹄疫病毒和水泡性口炎病毒的二重荧光RT-LAMP检测方法。根据口蹄疫病毒(FMDV)3D基因和水泡性口炎病毒(VSV)N基因的保守序列,设计了2套特异性引物,在每条内引物的5′端标记荧光基团,通过扩增产物颜色判断检测结果。优化反应条件,建立了可同时检测口蹄疫病毒和水泡性口炎病毒的二重荧光RT-LAMP方法。结果显示,该方法灵敏性高,每个反应最低能够检测到100个拷贝混合模板;特异性好,能在同一个反应管里检测到两种病毒,对其他牛病原体无扩增;干扰性小,扩增效率不受模板浓度影响。本研究建立的口蹄疫病毒和水泡性口炎病毒二重荧光RT-LAMP方法具有简便、快速、特异、敏感等优点,可用于FMDV和VSV的临床检测和流行病学调查。     

水疱性口炎病毒RT-LAMP快速检测方法的研究

根据逆转录环介导等温扩增(RT-LAMP)原理,针对水疱性口炎病毒(VSV)糖蛋白G基因序列中的6个区域设计内外各1对特异引物,建立扩增VSV糖蛋白(G)基因的RT-LAMP方法。扩增产物电泳呈特异的阶梯状条带分布,扩增产物加SYBR GREEN I染色呈特征性的黄绿色,肉眼可直接观察判定。同时,还建立了可以进行定量检测的实时RT-LAMP方法。特异性试验显示,本方法可快速检验鉴别VSV与口蹄疫病毒(FMDV)和猪水泡病病毒(SVDV)。敏感性试验显示,建立的实时RT-LAMP方法检测VSVRNA的最低检测量为0.01 PFU,比实时荧光RT-PCR显著提高。建立的LAMP方法可检测p-VSVNJ质粒DNA的最低量为6.36×10-3pg/μL(1.4×103copies/μL),比PCR也显著提高。综合表明,本研究建立RT-LAMP检测VSV的方法具有特异、敏感、快速、简便的特点,具有开发应用前景。     

多重RT-PCR检测猪口蹄疫病毒、猪水泡病病毒和猪水疱性口炎病毒的研究

建立了一种同时检测猪口蹄疫病毒(FMDV)、猪水泡病病毒(SVDV)和猪水疱性口炎病毒(VSV)三种病原体的多重RT-PCR方法。参照文献报道的基因序列,设计合成了三对特异性引物;PCR扩增条件进行优化后,用这三对引物对同一样品中的FMDV、SVDV、VSVRNA模板进行扩增,结果同时得到了三条特异性条带,大小与试验设计相符:FMDV(208bp)、SVDV(862bp)、VSV(638bp),且对猪瘟病毒(CSFV)、猪繁殖与呼吸综合症病毒(PRRSV)和猪传染性胃肠炎病毒(TGEV)核酸扩增结果为阴性;三种病毒RNA模板检出的最小量均为10fg。试验证明,此方法经济、快速、敏感、特异,可用于FMDV、SVDV和VSV这三种猪水泡性疾病的鉴别诊断及流行病学调查。     

蓝舌病、口蹄疫、小反刍兽疫和水泡性口炎多重PCR检测方法的建立

为建立一种检测并鉴别蓝舌病病毒、口蹄疫病毒、小反刍兽疫病毒和水泡性口炎病毒感染的方法,针对蓝舌病病毒NS3基因、口蹄疫病毒3D基因、小反刍兽疫病毒N基因和水泡性口炎病毒N基因序列设计引物,优化反应体系和扩增条件,建立了一种同时检测4种病毒的多重PCR方法。对建立的多重PCR检测方法的特异性及敏感性进行检验,结果表明建立的多重PCR检测方法敏感性强、特异性良好,对4种病毒的最低检出限分别为PPRV 103 copies/μL、BTV 103 copies/μL、VSV 103 copies/μL和FMDV 102 copies/μL。本方法的建立对临床感染蓝舌病等4种病毒的病畜进行快速检测具有十分重要的意义。     

应用RT-PCR方法快速检测水泡性口炎病毒

针对水泡性口炎病毒(VSV)的两种血清型设计了2对引物，建立RT-PCR方法，用于检测VSV。VSV接种细胞出现明显的细胞病变，经RT-PCR检测为阳性，而检测口蹄疫、猪水泡病均为阴性，说明引物具有较好的特异性。     

多重PCR同时检测口蹄疫病毒、猪水疱病病毒和水疱性口炎病毒

根据基因库中的口蹄疫病毒（FM—DV）,猪水疱病病毒（SVDV）和水疱性口炎病毒（VSV）各基因序列,设计了与FMDV,SVDV和VSV互补的3对特异性引物,对样品中的cDNA模板进行了多重PCR扩增及反应条件的优化,结果同时得到与设计相符合的3条特异性条带,分别为189bp,125bp和300bp。用这3对引物对病毒样品cDNA模板进行多次扩增,均能稳定得到与设计相符合的3条特异性条带。本试验能特异、敏感、快速地鉴定FMDV,SVDV和VSV。     

水泡性口炎病毒血清型特异LUX实时荧光RT-PCR检测方法的建立

采用LUX荧光核酸扩增技术原理,以水泡性口炎病毒（VSV）NJ、IND型NS基因为模板分别设计并合成单标记LUX荧光引物,建立血清型特异的VSV荧光RT—PCR检测方法。试验表明,两种型特异的LUX荧光RT-PCR能分别特异地鉴定VSV血清型,对口蹄疫、猪水泡病等病毒以及对照细胞、健康动物组织RNA样品的检测结果均为阴性。对比检测试验表明,LUX荧光RT—PCR的检测敏感性比常规RT-PCR提高达10倍以上,对VSV细胞增殖病毒液的检测灵敏度可达1 TCID50。对人工感染豚鼠样品以及临床样品的检测试验证实,该LUX荧光RT—PCR可有效检测到人工感染动物组织以及进口牛临床样品中的水泡性口炎病毒,并能鉴定感染病毒血清型。所报道的检测方法,包括样品核酸提取、LUX荧光RT—PCR以及熔解曲线分析,可在3h内完成。     

应用实时荧光定量TaqMan RT-PCR检测口蹄疫病毒

按照口蹄疫病毒(FMDV)聚合酶3D基因序列,设计合成了引物和探针,经各反应务件的优化,建立了实时荧光定量RT-PcR技术,对细胞培养物、水泡液、水泡皮及分泌物、血液中的FMDV进行了特异性检测和敏感性试验。结果,用300nmol／L的引物浓度和200nmol／L探针浓度,获得的CT值较小,而△Rn最大;可检测到相当于9．1TCID50的病毒RNA;与VSV和其他水泡性病毒不发生交叉反应;制作的标准曲线中各浓度范围内有极好的线性关系,且线性范围宽,相关系数为0．984;组内和组间试验重复性的变异系数(CV)分别为5．4％和6．7％;与常规RT-PCR相比较,该方法具有快速、特异、敏感、可定量,并可同时检测大量样品等优点。     

塞尼卡病毒与口蹄疫病毒双重RT-PCR鉴别检测方法的建立

2014~2015年,美国、巴西等国爆发了一种症状类似于口蹄疫的水泡性疾病,病原被确定为塞尼卡病毒A(Senecavirus A,SVA)。为了鉴别和诊断塞尼卡病毒A和口蹄疫病毒(Foot-and-mouth disease virus,FMDV),本研究针对塞尼卡病毒的VP1基因和口蹄疫的5’UTR基因,合成特异性引物,优化了反应体系和扩增条件,建立了一种可同时检测塞尼卡病毒A和口蹄疫病毒的双重RT-PCR方法。特异性和敏感性试验结果表明,建立的双重RT-PCR检测方法特异性好,敏感性强,对塞尼卡病毒A和口蹄疫病毒最低检出量分别为104 copies/μL、103 copies/μL。本研究建立的方法对临床快速鉴别塞尼卡病毒A和口蹄疫病毒感染具有重要意义。     

Response of cattle persistently infected with bovine virus diarrhoea virus to bovine leukosis virus

Six cattle persistently infected with bovine virus diarrhoea virus (BVDV) and seronegative, and two control, virus negative seropositive cattle were inoculated with lymphocytes infected with bovine leukosis virus (BLV). The two controls produced a normal immune response to BLV, developing antibodies at four and five weeks after inoculation. Two of the six cattle persistently infected with BVDV developed a strong antibody response by six weeks after inoculation with BLV. Four developed a depressed response to BLV, characterised in three by a 'hooking' reaction in the immunodiffusion test which persisted in successive bleedings but was interspersed occasionally by a weak positive reaction. In one of these animals, a series of 'hooking' reactions was followed by a number of negative results. The fourth animal remained serologically negative until 16 weeks after inoculation when a 'hooking' reaction was observed followed by a series of negative results. BLV was isolated from all the cattle persistently infected with BVDV at 42 or 58 weeks after inoculation regardless of whether the serum samples gave negative, 'hooking', weak positive or positive reactions in the immunodiffusion test. BLV was consistently isolated from the nasal secretions of a steer which was BVDV negative but seropositive. The possibility of decreased immune responsiveness to BLV in animals persistently infected with BVDV should be considered when formulating regulations governing the testing of animals for freedom from BLV.     

Detection of bovine virus diarrhea virus in a live bovine herpes virus 1 marker vaccine

In February 1999, 12 Dutch herds were vaccinated with a live bovine herpesvirus 1 vaccine from which bovine virus diarrhea virus (BVDV) could be isolated. All vaccine batches that were on the Dutch market and that had not yet reached the expiry date were tested for BVDV. In total, seven of 82 batches tested were found positive. Batch numbers TX3607, VB3914, VB3915, VB4046, TW3391, and TV3294 were positive for BVDV type 1, and batch number WG4622 was positive for BVDV type 2. This latter batch induced clinical signs of BVDV in an animal experiment with susceptible animals.     

Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus,Aino virus and Chuzan virus against Schmallenberg virus infection

Schmallenberg virus (SBV), an arthropod borne pathogen, spread rapidly throughout the majority of Europe since 2011. It can cause a febrile disease, milk drop, diarrhea, and fetal malformation in ruminants. SBV, a member of the Simbu serogroup within the genus Orthobunyavirus, is closely related to Akabane virus (AKAV) and Aino virus (AINOV) among others. In the present study, 4 Holstein-Friesian calves were immunized twice four weeks apart with a multivalent, inactivated vaccine against AKAV and AINOV. Another 4 calves were kept as unvaccinated controls. All animals were clinically, serologically and virologically examined before and after challenge infection with SBV. AKAV- and AINOV-specific neutralizing antibodies were detected one week before challenge infection, while SBV-specific antibodies were detectable only thereafter. SBV genome was detected in all vaccinated animals and 3 out of 4 controls in serum samples taken after challenge infection. In conclusion, the investigated vaccine was not able to prevent an SBV-infection. Thus, vaccines for other related Simbu serogroup viruses can not substitute SBV-specific vaccines as an instrument for disease control.     

登革病毒及其所致疾病的研究概况

登革病毒所致疾病包括登革热、登革出血热及登革休克综合征，是全球分布最广、发病最多的一种虫媒传染病．近年发病呈上升趋势，严重威胁人类健康。文章概述了登革热病原学、流行病学、发病机制、临床表现、诊断进展、治疗、预防和控制等。     

The control of bovine virus diarrhoea virus in Shetland

A scheme to control and eradicate bovine virus diarrhoea (BVD) was initiated in 1994 in the Shetland Islands by local veterinary surgeons and funded by the Shetland Islands Council and Shetland Enterprise Company. Over a 3-year period every bovine animal on the islands was blood-sampled (heparinised) and laboratory tested using MAb-based ELISAs for BVD virus antibody and antigen detection for evidence of disease. A number of BVD virus positive animals (40) were found and culled. A total of 6150 animals were tested from 213 herds and 43% herds were found to be BVD naive. The remaining herds had experienced infection and contained many BVD antibody positive animals. Some repeat sampling of stock in infected herds determined further virus positive animals which were slaughtered and in 1997 the scheme ceased since it appeared that there were no persistent excretors present. The major risk to the Shetland Islands is from bought-in stock, especially animals which are imported in calf. It is vital that all bought-in animals are tested and proven to be free of BVD virus if these animals are in calf, the calves must be tested a birth to determine status. It is strongly advised that only bulls and bulling heifers or cows are bought into Shetland in future, thus, protecting the present stock. Continued surveillance will be required to claim eradication of BVD from Shetland.     

Diagnosis of feline leukemia virus and feline immunodeficiency virus infections

Feline leukemia virus is an oncogenic retrovirus that can result in a wide variety of neoplastic and non-neoplastic diseases, including immunosuppression. Diagnosis of FeLV infection can be achieved by several methods, including virus isolation; IFA assay of a peripheral blood smear; and detection of a viral protein (called p27) by ELISA testing of whole blood, plasma, serum, saliva, or tears. Commercially available ELISA kits have revolutionized FeLV testing and have become very popular as "in-house" procedures. This article discusses the interpretation of ELISA results and compares them with IFA assay findings. Feline immunodeficiency virus is a lentivirus that causes immunosuppression, but not neoplasia, in cats. It originally was called feline T-lymphotropic lentivirus. Differentiating FIV infection from the immunosuppressive type of FeLV infection requires virus isolation or serology. The most rapid method for diagnosis of FIV infection is ELISA testing for antiviral antibody.